Recorded Chinese product: 注射用盐酸尼莫司汀注射用盐酸尼莫司汀
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司
主要成分Active Ingredients
- 尼莫司汀Nimo Siting
药物知识说明
尼莫司汀是一种在国家药监局注册认定的药品。标注生产企业为西安海欣制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司、西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司、西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用盐酸尼莫司汀) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 西安海欣制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司, 西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司, 西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用盐酸尼莫司汀Recorded Chinese product: 注射用盐酸尼莫司汀
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 25mg25 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 西安海欣制药有限公司Chinese legal name: 西安海欣制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20046672
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20046672
Manufacturer
Chinese legal name: 西安海欣制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20046672
生产企业
西安海欣制药有限公司(国产)
适应症
脑肿瘤、消化道癌（胃癌、肝癌、结肠、直肠癌）、肺癌、恶性淋巴瘤、慢性白血病等。
用法用量
通常，本剂按每5mg溶于注射用水1ml的比例溶解下述剂量，供静脉或动脉给药。 1.以盐酸尼莫司汀计，按体重给药，1次给2－3mg/kg，其后据血象停药4～6周，再次给药，如此反复，直到临床满意的效果。 2.以盐酸尼莫司汀计，将1次量2mg/kg，隔1周给药，2－3次后，据血象停药4～6周，再次给药，如此反复，直到临床满意的效果。
不良反应
用药后会出现白细胞减少、血小板减少、贫血、出血倾向、过敏症，肝肾功能损害、食欲不振、恶心、呕吐、口内炎、腹泻。偶出现间质性肺炎。也可乏力、发热、头痛、眩晕、痉挛、脱发、低蛋白血症。有时出现GOT、GPT和BUN上升、蛋白尿。
禁忌
骨髓功能抑制患者和对本品有严重过敏症者禁用
注意事项
1.肝肾功能不全者及儿童、老人慎用，严重骨髓抑制和对本品过敏者及水痘病患者禁用。2.每周必须进行血液及肝肾功能检查，密切注意感染及出血倾向。3.本品不能肌注或皮下给药，静注不可使药液外漏，以免局部硬结坏死。
贮藏
遮光，密闭保存。
规格
25mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.